Get App Open
In App
Lending
Lending
Open App
you are here:

Mankind Pharma Ltd.

BSE: 543904 | NSE: MANKIND |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE634S01028 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 10, 10:39
2478.15 -1.45 (-0.06%)
Volume
AVERAGE VOLUME
5-Day
23,200
10-Day
23,982
30-Day
25,051
1,485
  • Prev. Close

    2479.60

  • Open Price

    2489.05

  • Bid Price (Qty.)

    2476.25 (14)

  • Offer Price (Qty.)

    2479.10 (14)

NSE Live

Oct 10, 10:39
2478.10 -1.30 (-0.05%)
Volume
AVERAGE VOLUME
5-Day
462,327
10-Day
559,087
30-Day
795,408
25,022
  • Prev. Close

    2479.40

  • Open Price

    2480.00

  • Bid Price (Qty.)

    2476.50 (6)

  • Offer Price (Qty.)

    2478.20 (8)

Financials

Profit & Loss account of Mankind Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 4,730.15 3,871.41 3,921.76 3,511.78 3,171.28  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 5.36 18.86 22.55  
Revenue From Operations [Net] 4,730.15 3,871.41 3,916.40 3,492.92 3,148.73  
Total Operating Revenues 4,794.41 3,877.49 3,918.14 3,507.06 3,149.51  
Other Income 93.85 64.33 200.88 89.37 72.73  
Total Revenue 4,888.26 3,941.82 4,119.01 3,596.43 3,222.24  
EXPENSES  
Cost Of Materials Consumed 434.87 216.32 140.34 123.58 128.98  
Purchase Of Stock-In Trade 1,182.55 1,115.85 1,213.18 1,283.43 1,088.64  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -44.51 22.08 77.25 -111.25 -12.60  
Employee Benefit Expenses 991.47 785.02 798.01 662.72 573.89  
Finance Costs 10.62 39.04 17.94 1.40 1.45  
Depreciation And Amortisation Expenses 61.77 38.39 27.52 18.60 36.70  
Other Expenses 986.57 1,033.83 912.01 836.35 731.53  
Total Expenses 3,623.34 3,250.53 3,186.24 2,814.82 2,548.59  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,264.92 691.30 932.77 781.61 673.65  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 1,264.92 691.30 932.77 781.61 673.65  
Tax Expenses-Continued Operations  
Current Tax 336.58 187.46 256.70 218.58 206.01  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -35.11 -10.20 -10.09 24.82 -1.55  
Tax For Earlier Years 5.23 0.00 0.00 0.00 0.00  
Total Tax Expenses 306.70 177.26 246.61 243.39 204.45  
Profit/Loss After Tax And Before ExtraOrdinary Items 958.23 514.04 686.16 538.22 469.20  
Profit/Loss From Continuing Operations 958.23 514.04 686.16 538.22 469.20  
Profit/Loss For The Period 958.23 514.04 694.36 538.22 469.20  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 23.92 12.83 17.33 268.71 234.25  
Diluted EPS (Rs.) 23.92 12.83 17.33 268.71 234.25  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 302.44 24.04 300.44 0.00 300.44  
Tax On Dividend 61.82 4.89 35.58 0.00 60.82  
Equity Dividend Rate (%) 755.00 4.00 750.00 0.00 1,500.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970